Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma

The Journal of Immunology(2025)10.1093/jimmun/vkaf242Source: DataRank Database

Development of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinoma is a research paper published in The Journal of Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)Impact (FWCI 0.38)OA: hybridTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Franklyn I. Bennett ORCID,Emilie A. K. Warren ORCID,Kailey M. Oppat,Megan M. Wyatt ORCID,Jacklyn Hammons

Live enrichment

PubMed:40972018 PMC:PMC12704411 OpenAlex:https://openalex.org/W4414368668

National Cancer Institute

Grant: T32 CA272392-01A1

National Cancer Institute

Grant: 1F30CA291027-01A1

National Cancer Institute

Grant: NCI T32 CA275777

NIH

Grant: UL1TR002378

NIH

Grant: TL1TR002382

NCI

Grant: R01CA228406

NCI

Grant: R21CA266088-01

NCI

Grant: R21CA270903

NCI

Grant: R01CA175061

NCI

Grant: R01CA208514

NCI

Grant: R01CA275199

NIDCR NIH HHS

Grant: R21 DE029592

NCI NIH HHS

Grant: T32 CA275777

NCI NIH HHS

Grant: F30 CA291027

NCI NIH HHS

Grant: P30 CA138292

NCI NIH HHS

Grant: R21 CA266088

NCI NIH HHS

Grant: T32 CA272392

National Institutes of Health

Abraham and Phyllis Katz Foundation

Melanoma Research Foundation

National Center for Advancing Translational Sciences

V Foundation and Emory University

NIH HHS

Cholangiocarcinoma Foundation

Winship Cancer Institute and Department of Hematology and Medical Oncology

FWCI

0.38

Citation Percentile

0.6%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/jimmunol/advance-article-pdf/doi/10.1093/jimmun/vkaf242/64286171/vkaf242.pdf

publisherhttps://academic.oup.com/jimmunol/advance-article-pdf/doi/10.1093/jimmun/vkaf242/64286171/vkaf242.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/215/1/vkaf242/64286171/vkaf242.pdf

journalhttps://doi.org/10.1093/jimmun/vkaf242

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40972018

Fields of Study

Immunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction

MeSH Terms

AnimalsAntigens, NeoplasmBile Duct NeoplasmsDisease Models, AnimalFemaleHumansMice, Inbred C57BLImmunotherapy, AdoptiveLymphocytes, Tumor-InfiltratingCD3 ComplexCholangiocarcinomaCell Line, TumorMice

Keywords

Tumor-infiltrating lymphocytesAdoptive cell transferCombination therapyImmunotherapyIn vivoDownregulation and upregulationCD3Ex vivoCholangiocarcinomaOrthotopic Mouse ModelTumor Infiltrating Lymphocytes (Tils)Pd-l1 BlockadeAdoptive Cell Transfer (Act)